At the Leading Edge

Our dedicated researchers are focused on improving patient health through the application of the most up-to-date research technology and techniques.
 

As we work tirelessly to challenge unmet patient needs, our focus is on:

  • Understanding the molecular mechanisms underpinning disease
  • Applying new technology in an innovative and thoughtful manner
  • Generating diagnosis hypotheses early to incorporate into clinical studies
  • Leveraging collaboration to capitalize on cutting-edge science

Advanced Formulations

Our scientists and researchers ensure optimal product formulation through analytical method development, stability testing and close management of bioequivalence and other clinical studies.

Making Medicines

Teva’s R&D group has an exceptional track record in translating early drug opportunities into clinically-proven drug candidates. Our research and manufacturing facilities are fully equipped to support both GLP development and cGMP manufacture.

Special Delivery Technologies

In therapeutic delivery, our capabilities have expanded beyond tablets, capsules, liquids, ointments and creams to a broad range of dosage forms and delivery systems. These include sterile devices, long acting release injectables, transdermal patches and films, and nasal suspensions. Our R&D group continues to develop an array of special delivery technologies ranging from extended-release to drug device combinations. We are also developing a pipeline of new inhaled respiratory therapies that will be easily administered through unique delivery systems including our Spiromax™ inhaler and MicroDose electronic dry powder inhaler system.



Our Technologies

Integrating our Technologies